Key Points
- CorVel insider Maxim Shishin sold 2,250 shares on June 12 at an average price of $60.59, totaling about $136,327. After the sale, he still owned 7,050 shares.
- CRVL shares fell 2.4% and opened at $58.89, giving the company a market value of about $2.99 billion. The stock has traded between $44.83 and $105.69 over the past 12 months.
- CorVel recently reported quarterly EPS of $0.61 on revenue of $248.55 million. Institutional ownership remains high, with hedge funds and other institutions holding about 51.36% of the stock.
CorVel Corp. (NASDAQ:CRVL - Get Free Report) insider Maxim Shishin sold 2,250 shares of CorVel stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $60.59, for a total value of $136,327.50. Following the transaction, the insider directly owned 7,050 shares in the company, valued at $427,159.50. The trade was a 24.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
CorVel Trading Down 2.4%
Shares of CRVL opened at $58.89 on Tuesday. The company has a market capitalization of $2.99 billion, a PE ratio of 27.52 and a beta of 0.99. CorVel Corp. has a 12 month low of $44.83 and a 12 month high of $105.69. The stock's 50-day moving average price is $58.08 and its two-hundred day moving average price is $60.06.
CorVel (NASDAQ:CRVL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 19th. The business services provider reported $0.61 earnings per share (EPS) for the quarter. The company had revenue of $248.55 million for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.51%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the business. Royal Bank of Canada raised its stake in CorVel by 12.5% during the 1st quarter. Royal Bank of Canada now owns 51,261 shares of the business services provider's stock worth $5,739,000 after buying an additional 5,703 shares during the period. AQR Capital Management LLC raised its stake in CorVel by 4.0% during the 1st quarter. AQR Capital Management LLC now owns 26,468 shares of the business services provider's stock worth $2,964,000 after buying an additional 1,013 shares during the period. Integrated Wealth Concepts LLC raised its stake in CorVel by 11.4% during the 1st quarter. Integrated Wealth Concepts LLC now owns 3,800 shares of the business services provider's stock worth $425,000 after buying an additional 389 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in CorVel by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,846 shares of the business services provider's stock worth $1,774,000 after buying an additional 702 shares during the period. Finally, Millennium Management LLC raised its stake in CorVel by 127.4% during the 1st quarter. Millennium Management LLC now owns 48,182 shares of the business services provider's stock worth $5,395,000 after buying an additional 26,990 shares during the period. 51.36% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on CRVL shares. Weiss Ratings downgraded CorVel from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, April 6th. Wall Street Zen raised CorVel from a "hold" rating to a "buy" rating in a research note on Saturday, May 30th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, CorVel has an average rating of "Sell".
Get Our Latest Research Report on CRVL
CorVel Company Profile
(
Get Free Report)
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers' compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel's integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company's product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
